Skip to main content
Clinical Trials/NCT05880407
NCT05880407RecruitingNot Applicable

Pilot Study of Percutaneous Correction of Hallux Valgus: Clinical-functional Evaluation of Outcome Randomized Study

Istituto Ortopedico Rizzoli1 site in 1 country40 target enrollmentStarted: February 22, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
40
Locations
1
Primary Endpoint
Visual Analog Score

Study Overview

Brief Summary

This is a pilot study with a randomized controlled design.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients of both sexes with adult hallux valgus with indication for corrective surgical treatment
  • •HVA (hallux valgus angle): 20°-40°
  • •IMA (intermetatarsal angle): 10°-20°

Exclusion Criteria

  • •Patients with instability of the first metatarsophalangeal joint
  • •Patients with severe morphostructural alterations or other pathologies in the foot and lower limb
  • •patients requiring additional surgical procedures
  • •patients with severe vascular and neurological systemic pathologies
  • •systemic pathologies that may impair bone consolidation

Arms & Interventions

standard treatment

Active Comparator

SERI osteotomy

Intervention: SERI osteotomy (Procedure)

experimental treatment

Experimental

percutaneous osteotomy according to Chevron

Intervention: percutaneous osteotomy according to Chevron (Procedure)

Outcomes

Primary Outcomes

Visual Analog Score

Time Frame: baseline

pain visual analog assessment

Visual Analog Score

Time Frame: 1 year

pain visual analog assessment

Secondary Outcomes

  • American Orhtopaedic Foot and Ankle Society forefoot score(baseline and aftef 1 year)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials